BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17327365)

  • 1. A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula.
    Elston J; Stein K
    J Public Health (Oxf); 2007 Jun; 29(2):157-64. PubMed ID: 17327365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the quality of mini-HTA.
    Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
    Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTA'd in the USA: A Comparison of ICER in the United States with NICE in England and Wales.
    Thokala P; Carlson JJ; Drummond M
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1162-1170. PubMed ID: 32857653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying rapid 'de-facto' HTA in resource-limited settings: experience from Romania.
    Lopert R; Ruiz F; Chalkidou K
    Health Policy; 2013 Oct; 112(3):202-8. PubMed ID: 23953877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary survey on the influence of rapid health technology assessments.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.
    Garfield S; Polisena J; S Spinner D; Postulka A; Y Lu C; Tiwana SK; Faulkner E; Poulios N; Zah V; Longacre M
    Value Health; 2016; 19(5):577-87. PubMed ID: 27565275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in cancer drug assessment between Spain and the United Kingdom.
    Lozano-Blázquez A; Dickson R; Fraga-Fuentes MD; Martínez-Martínez F; Calleja-Hernández MÁ
    Eur J Cancer; 2015 Sep; 51(13):1843-52. PubMed ID: 26119375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Technology Assessments in Radiology in Germany: Lack of Demand, Lack of Supply.
    Winkelmann C; Neumann T; Zeidler J; Prenzler A; Vogt B; Wacker FK
    Rofo; 2019 Jul; 191(7):635-642. PubMed ID: 30763963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferability of health technology assessment reports in Latin America: an exploratory survey of researchers and decision makers.
    Pichon-Riviere A; Augustovski F; García Martí S; Sullivan SD; Drummond M
    Int J Technol Assess Health Care; 2012 Apr; 28(2):180-6. PubMed ID: 22559762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negotiating commissioning pathways for the successful implementation of innovative health technology in primary care.
    Maniatopoulos G; Haining S; Allen J; Wilkes S
    BMC Health Serv Res; 2019 Sep; 19(1):648. PubMed ID: 31492139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment and primary data collection for reducing uncertainty in decision making.
    Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
    J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How is evidence on test performance synthesized for economic decision models of diagnostic tests? A systematic appraisal of Health Technology Assessments in the UK since 1997.
    Novielli N; Cooper NJ; Abrams KR; Sutton AJ
    Value Health; 2010 Dec; 13(8):952-7. PubMed ID: 21029247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment in India: the potential for improved healthcare decision-making.
    Kumar M; Ebrahim S; Taylor FC; Chokshi M; Gabbay J
    Natl Med J India; 2014; 27(3):159-63. PubMed ID: 25668089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment in the United Kingdom.
    Drummond M; Banta D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():178-81. PubMed ID: 19527538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
    Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.